Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen.
Saved in:
| Title: | Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen. |
|---|---|
| Authors: | Beom SH; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim JG; Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, 807 Hoguk-ro, Buk-gu, Daegu, 41404, Republic of Korea. jkk21c@knu.ac.kr., Baik SH; Section of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Gangnam Severance Hospital, 211 Eonju-Ro, Gangnam-Gu, Seoul, South Korea., Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea., Park I; Division of Hematology-Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, 774-21 Namdongdero, Namdong-Gu, Incheon, Republic of Korea., Park YS; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, Republic of Korea., Lee MA; Division of Medical Oncology, Department of Internal Medicine, Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee S; Division of Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, 73 Goryeodae-ro Seongbuk-gu, Seoul, 02841, South Korea., Jeon SY; Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea., Han SW; Department of Internal Medicine, Seoul National University Hospital and Seoul National University Cancer Research Institute, Seoul, Republic of Korea., Kang MH; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Samjeongja-ro 11, Changwon, Republic of Korea., Oh J; Division of Medical Oncology, Department of Internal Medicine, Yongin Severance Hospital, Yongin-si, Gyeonggi-do, Republic of Korea., Kim JS; Department of Surgery, Chungnam National University College of Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea., Kim JY; Division of Hematology and Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Dalgubeol-daero, Dalseo-gu, Daegu, Republic of Korea., Ahn MS; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea., Zang DY; Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang-si, Republic of Korea., Bae BN; Department of Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, 1342 Dongil-ro, Seoul, Republic of Korea., Jo HJ; Department of Surgery, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Republic of Korea., Kim HK; Division of Oncology, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea., Kim JH; Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea., Yoon JA; Medical Affairs of Oncology, Sanofi Korea, Seoul, Republic of Korea., Kim DH; Medical Affairs of Oncology, Sanofi Korea, Seoul, Republic of Korea.; GSK Korea, Seoul, Republic of Korea. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Mar; Vol. 149 (3), pp. 1131-1143. Date of Electronic Publication: 2022 Mar 27. |
| Publication Type: | Observational Study; Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
